The role of TNF-α in diabetic nephropathy:: Pathogenic and therapeutic implications

被引:181
作者
Navarro, Juan F.
Mora-Fernandez, Carmen
机构
[1] Hosp Nuestra Senora Candelaria, Serv Nefrol, Tenerife 38010, Spain
[2] Univ Hosp Nuestra Senora Candelaria, Res Unit, Tenerife 38010, Spain
[3] Spanish Natl Res Council, Ctr Biol Res, Madrid 28006, Spain
关键词
tumor necrosis factor-alpha; chronic kidney disease; end-stage renal disease; diabetic nephropathy;
D O I
10.1016/j.cytogfr.2006.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus and its complications are a public health problem. Diabetic nephropathy has become the main cause of renal failure, and furthermore is associated with a dramatic increase in cardiovascular risk. Unfortunately, the mechanisms leading to the development and progression of renal injury in diabetes are not yet fully known. There is now evidence that activated innate immunity and inflammation are relevant factors in the pathogenesis of diabetes. Furthermore, different inflammatory molecules, including pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), play a critical role in the development of microvascular diabetic complications, including nephropathy. This review discusses the role of TNF-alpha as a pathogenic factor in renal injury, focusing on diabetic nephropathy, and describes potential treatment strategies based on modulation of TNF-alpha activity. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 123 条
[1]   The changing patterns of chronic kidney disease: The need to develop strategies for prevention relevant to different regions and countries [J].
Atkins, RC .
KIDNEY INTERNATIONAL, 2005, 68 :S83-S85
[2]   The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study [J].
Barzilay, JI ;
Abraham, L ;
Heckbert, SR ;
Cushman, M ;
Kuller, LH ;
Resnick, HE ;
Tracy, RP .
DIABETES, 2001, 50 (10) :2384-2389
[3]   TUMOR NECROSIS FACTOR STIMULATES PROSTAGLANDIN PRODUCTION AND CYCLIC-AMP LEVELS IN RAT CULTURED MESANGIAL CELLS [J].
BAUD, L ;
PEREZ, J ;
FRIEDLANDER, G ;
ARDAILLOU, R .
FEBS LETTERS, 1988, 239 (01) :50-54
[4]  
BAUD L, 1995, MINER ELECTROL METAB, V21, P336
[5]   TUMOR-NECROSIS-FACTOR-ALPHA AND MESANGIAL CELLS [J].
BAUD, L ;
FOUQUERAY, B ;
PHILIPPE, C ;
AMRANI, A .
KIDNEY INTERNATIONAL, 1992, 41 (03) :600-603
[6]   On the prognosis of IDDM patients with large kidneys [J].
Baumgartl, HJ ;
Sigl, G ;
Banholzer, P ;
Haslbeck, M ;
Standl, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (03) :630-634
[7]   Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults [J].
Beaglehole, R ;
Yach, D .
LANCET, 2003, 362 (9387) :903-908
[8]  
BERTANI T, 1989, AM J PATHOL, V134, P419
[9]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[10]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798